Morbus Parkinson: alpha-Dihydroergocryptin ; ein neuer Dopamin-Agonist
Saved in:
| Format: | Book |
|---|---|
| Language: | German |
| Published: |
Stuttgart [u.a.]
Thieme
1995
|
| Subjects: | |
| Online Access: | Inhaltsverzeichnis |
| Physical Description: | IX, 62 S. Ill., graph. Darst. |
| ISBN: | 3131041617 |
Staff View
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV010409279 | ||
| 003 | DE-604 | ||
| 005 | 19960412 | ||
| 007 | t| | ||
| 008 | 950925s1995 gw ad|| |||| 00||| ger d | ||
| 016 | 7 | |a 945576005 |2 DE-101 | |
| 020 | |a 3131041617 |9 3-13-104161-7 | ||
| 035 | |a (OCoLC)36352307 | ||
| 035 | |a (DE-599)BVBBV010409279 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a ger | |
| 044 | |a gw |c DE | ||
| 049 | |a DE-355 | ||
| 084 | |a YG 5515 |0 (DE-625)153506:12921 |2 rvk | ||
| 245 | 1 | 0 | |a Morbus Parkinson |b alpha-Dihydroergocryptin ; ein neuer Dopamin-Agonist |c hrsg. von G. Deuschl |
| 264 | 1 | |a Stuttgart [u.a.] |b Thieme |c 1995 | |
| 300 | |a IX, 62 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 650 | 4 | |a Antiparkinson Agents |x therapeutic use | |
| 650 | 4 | |a Dihydroergotoxine |x therapeutic use | |
| 650 | 4 | |a Parkinson Disease |x drug therapy | |
| 650 | 0 | 7 | |a Dihydroergocryptin |0 (DE-588)4407472-4 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Dopaminantagonist |0 (DE-588)4299915-7 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Parkinson-Krankheit |0 (DE-588)4044683-9 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Parkinson Disease |x drug therapy |2 mesh |
| 650 | 0 | 7 | |a Antiparkinson Agents |x therapeutic use |2 mesh |
| 650 | 0 | 7 | |a Dihydroergotoxine |x therapeutic use |2 mesh |
| 655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
| 689 | 0 | 0 | |a Parkinson-Krankheit |0 (DE-588)4044683-9 |D s |
| 689 | 0 | 1 | |a Dopaminantagonist |0 (DE-588)4299915-7 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Parkinson-Krankheit |0 (DE-588)4044683-9 |D s |
| 689 | 1 | 1 | |a Dihydroergocryptin |0 (DE-588)4407472-4 |D s |
| 689 | 1 | |5 DE-604 | |
| 700 | 1 | |a Deuschl, Günther |e Sonstige |0 (DE-588)141680679 |4 oth | |
| 856 | 4 | 2 | |m DNB Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=006932261&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-006932261 | |
Record in the Search Index
| _version_ | 1828390375895597056 |
|---|---|
| adam_text |
INHALTSVERZEICHNIS
ADRESSEN
V
VORWORT
VLL
G.
DEUSCHL
GRUNDPRINZIPIEN
DER
DIFFERENTIALDIAGNOSE
UND
DIFFERENTIALTHERAPIE
DES
MORBUS
PARKINSON
1
E.
SCHNEIDER
ALPHA-DIHYDROERGOCRYPTIN
-
PHARMAKOLOGIE
UND
KLINISCHE
EFFEKTE
17
INTERVIEW
MIT
F.
STOCCHI
YYDIE
FRUEHZEITIGE
GABE
VON
DOPAMIN
AGONISTEN
VERZOEGERT
DAS
AUFTRETEN
VON
FLUKTUATIONEN
"
43
INTERVIEW
MIT
F.
PICCOLI
YYDIE
STAERKE
VON
DIHYDROERGOCRYPTIN
IST
SEINE
GUTE
VERTRAEGLICHKEIT
"
49
INTERVIEW
MIT
L
BATTISTIN
YYDER
PATIENT
ERWARTET
HILFE
UND
KEINE
ZUSAETZLICHE
EINSCHRAENKUNG
DER
LEBENS
FUEHRUNG
"
55
SACHVERZEICHNIS
61 |
| any_adam_object | 1 |
| author_GND | (DE-588)141680679 |
| building | Verbundindex |
| bvnumber | BV010409279 |
| classification_rvk | YG 5515 |
| ctrlnum | (OCoLC)36352307 (DE-599)BVBBV010409279 |
| discipline | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000 c 4500</leader><controlfield tag="001">BV010409279</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">19960412</controlfield><controlfield tag="007">t|</controlfield><controlfield tag="008">950925s1995 gw ad|| |||| 00||| ger d</controlfield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">945576005</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3131041617</subfield><subfield code="9">3-13-104161-7</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)36352307</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV010409279</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">ger</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">DE</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YG 5515</subfield><subfield code="0">(DE-625)153506:12921</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Morbus Parkinson</subfield><subfield code="b">alpha-Dihydroergocryptin ; ein neuer Dopamin-Agonist</subfield><subfield code="c">hrsg. von G. Deuschl</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Stuttgart [u.a.]</subfield><subfield code="b">Thieme</subfield><subfield code="c">1995</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">IX, 62 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antiparkinson Agents</subfield><subfield code="x">therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Dihydroergotoxine</subfield><subfield code="x">therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Parkinson Disease</subfield><subfield code="x">drug therapy</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Dihydroergocryptin</subfield><subfield code="0">(DE-588)4407472-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Dopaminantagonist</subfield><subfield code="0">(DE-588)4299915-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Parkinson-Krankheit</subfield><subfield code="0">(DE-588)4044683-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Parkinson Disease</subfield><subfield code="x">drug therapy</subfield><subfield code="2">mesh</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Antiparkinson Agents</subfield><subfield code="x">therapeutic use</subfield><subfield code="2">mesh</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Dihydroergotoxine</subfield><subfield code="x">therapeutic use</subfield><subfield code="2">mesh</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Parkinson-Krankheit</subfield><subfield code="0">(DE-588)4044683-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Dopaminantagonist</subfield><subfield code="0">(DE-588)4299915-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Parkinson-Krankheit</subfield><subfield code="0">(DE-588)4044683-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Dihydroergocryptin</subfield><subfield code="0">(DE-588)4407472-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Deuschl, Günther</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)141680679</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">DNB Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=006932261&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-006932261</subfield></datafield></record></collection> |
| genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
| genre_facet | Aufsatzsammlung |
| id | DE-604.BV010409279 |
| illustrated | Illustrated |
| indexdate | 2025-04-03T14:02:21Z |
| institution | BVB |
| isbn | 3131041617 |
| language | German |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-006932261 |
| oclc_num | 36352307 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | IX, 62 S. Ill., graph. Darst. |
| publishDate | 1995 |
| publishDateSearch | 1995 |
| publishDateSort | 1995 |
| publisher | Thieme |
| record_format | marc |
| spelling | Morbus Parkinson alpha-Dihydroergocryptin ; ein neuer Dopamin-Agonist hrsg. von G. Deuschl Stuttgart [u.a.] Thieme 1995 IX, 62 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Antiparkinson Agents therapeutic use Dihydroergotoxine therapeutic use Parkinson Disease drug therapy Dihydroergocryptin (DE-588)4407472-4 gnd rswk-swf Dopaminantagonist (DE-588)4299915-7 gnd rswk-swf Parkinson-Krankheit (DE-588)4044683-9 gnd rswk-swf Parkinson Disease drug therapy mesh Antiparkinson Agents therapeutic use mesh Dihydroergotoxine therapeutic use mesh (DE-588)4143413-4 Aufsatzsammlung gnd-content Parkinson-Krankheit (DE-588)4044683-9 s Dopaminantagonist (DE-588)4299915-7 s DE-604 Dihydroergocryptin (DE-588)4407472-4 s Deuschl, Günther Sonstige (DE-588)141680679 oth DNB Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=006932261&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Morbus Parkinson alpha-Dihydroergocryptin ; ein neuer Dopamin-Agonist Antiparkinson Agents therapeutic use Dihydroergotoxine therapeutic use Parkinson Disease drug therapy Dihydroergocryptin (DE-588)4407472-4 gnd Dopaminantagonist (DE-588)4299915-7 gnd Parkinson-Krankheit (DE-588)4044683-9 gnd Parkinson Disease drug therapy mesh Antiparkinson Agents therapeutic use mesh Dihydroergotoxine therapeutic use mesh |
| subject_GND | (DE-588)4407472-4 (DE-588)4299915-7 (DE-588)4044683-9 (DE-588)4143413-4 |
| title | Morbus Parkinson alpha-Dihydroergocryptin ; ein neuer Dopamin-Agonist |
| title_auth | Morbus Parkinson alpha-Dihydroergocryptin ; ein neuer Dopamin-Agonist |
| title_exact_search | Morbus Parkinson alpha-Dihydroergocryptin ; ein neuer Dopamin-Agonist |
| title_full | Morbus Parkinson alpha-Dihydroergocryptin ; ein neuer Dopamin-Agonist hrsg. von G. Deuschl |
| title_fullStr | Morbus Parkinson alpha-Dihydroergocryptin ; ein neuer Dopamin-Agonist hrsg. von G. Deuschl |
| title_full_unstemmed | Morbus Parkinson alpha-Dihydroergocryptin ; ein neuer Dopamin-Agonist hrsg. von G. Deuschl |
| title_short | Morbus Parkinson |
| title_sort | morbus parkinson alpha dihydroergocryptin ein neuer dopamin agonist |
| title_sub | alpha-Dihydroergocryptin ; ein neuer Dopamin-Agonist |
| topic | Antiparkinson Agents therapeutic use Dihydroergotoxine therapeutic use Parkinson Disease drug therapy Dihydroergocryptin (DE-588)4407472-4 gnd Dopaminantagonist (DE-588)4299915-7 gnd Parkinson-Krankheit (DE-588)4044683-9 gnd Parkinson Disease drug therapy mesh Antiparkinson Agents therapeutic use mesh Dihydroergotoxine therapeutic use mesh |
| topic_facet | Antiparkinson Agents therapeutic use Dihydroergotoxine therapeutic use Parkinson Disease drug therapy Dihydroergocryptin Dopaminantagonist Parkinson-Krankheit Aufsatzsammlung |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=006932261&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT deuschlgunther morbusparkinsonalphadihydroergocryptineinneuerdopaminagonist |